Question 1

How many shares of IBRX does Beacon Pointe Advisors, LLC own?

Accepted Answer

As of 2026-Q1, Beacon Pointe Advisors, LLC holds 40,227 shares of IBRX (IMMUNITYBIO INC).

Question 2

What is Beacon Pointe Advisors, LLC's IBRX position worth?

Accepted Answer

As of 2026-Q1, Beacon Pointe Advisors, LLC's IBRX position is worth $308,542.

Question 3

Is Beacon Pointe Advisors, LLC buying or selling IBRX?

Accepted Answer

In 2026-Q1, Beacon Pointe Advisors, LLC increased their IBRX position (+25.5% change in shares).

Question 4

When did Beacon Pointe Advisors, LLC first buy IBRX?

Accepted Answer

Based on available 13F filings, Beacon Pointe Advisors, LLC first reported a position in IBRX in 2024-Q3. They have held the position across 11 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q1 Latest	Increased	40,227	+25.5%	$308,542	0.0%	$10.00	29
2025-Q4	Decreased	32,046	-3.0%	$63,452	0.0%	$1.98	0
2025-Q3	Increased	33,042	+26.9%	$81,284	0.0%	$2.57	26
2025-Q2	Unchanged	26,042	0.0%	$68,751	0.0%	$2.70	0
2025-Q1	Unchanged	26,042	0.0%	$78,386	0.0%	$3.14	0
2024-Q4	Unchanged	26,042	0.0%	$66,668	0.0%	$2.68	0
2024-Q3	Unchanged	26,042	0.0%	$96,876	0.0%	$3.93	0